1st Quarter - Report

ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG) for CARIS SCIENCE, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Precision medicine policies. Appropriate regulatory oversight of diagnostic testing. Coverage and reimbursement of Next Generation Sequencing and other technologies.

Foreign entity interest: Caris Life Sciences, LTD, as the parent company, has an indirect interest in Caris Science Inc.

LobbyistCovered position, as disclosed
AMY JENSEN CUNNIFFE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Precision medicine policies. Appropriate regulatory oversight of diagnostic testing. Coverage and reimbursement of Next Generation Sequencing and other technologies.

Foreign entity interest: Caris Life Sciences, LTD, as the parent company, has an indirect interest in Caris Science Inc.

LobbyistCovered position, as disclosed
AMY JENSEN CUNNIFFE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.